NCT06821074 Defocus-Enhanced vs. Single Vision Spectacles in Myopia Control Visual Function Training
| NCT ID | NCT06821074 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Visionly Plus Eye Hospital |
| Condition | Myopia |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2025-02-08 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000 participants in total. It began in 2025-02-08 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to compare the effectiveness of vision function training using defocus-enhanced spectacles (DIMS) versus single vision spectacles combined with vision function training in controlling myopia progression in children aged 6-18 years.
Eligibility Criteria
Inclusion Criteria: * Aged 6-18 years. * Diagnosed myopia with SER between -0.50D and -4.00D. * Astigmatism ≤ 2.50DC. * Anisometropia \< 1.25D. Exclusion Criteria: * Suspected genetic syndromes (e.g., Stickler, Marfan). * Other eye diseases (e.g., glaucoma, cataracts, retinal abnormalities, strabismus). * Myopia progression \<0.50D SER in the last year.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06821074 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 18 Years, studying Myopia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06821074 currently recruiting?
Yes, NCT06821074 is actively recruiting participants. Contact the research team at roc001cn@gmail.com for enrollment information.
Where is the NCT06821074 trial being conducted?
This trial is being conducted at Beijing, China, Beijing, China.
Who is sponsoring the NCT06821074 clinical trial?
NCT06821074 is sponsored by Beijing Visionly Plus Eye Hospital. The trial plans to enroll 1,000 participants.